Systemic inflammatory response predicts survival following curative resection of colorectal cancer

被引:416
作者
McMillan, DC [1 ]
Canna, K [1 ]
McArdle, CS [1 ]
机构
[1] Univ Glasgow, Royal Infirm, Dept Surg, Glasgow G31 2ER, Lanark, Scotland
关键词
D O I
10.1002/bjs.4038
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Some studies have shown that the presence of a systemic inflammatory response, as evidenced by raised circulating concentrations of C-reactive protein (CRP), predicted recurrence and overall survival in patients with colorectal cancer. The aim of this study was to examine the relationship between the inflammatory response and overall and cancer-specific survival in patients undergoing potentially curative resection for colorectal cancer. Methods: A total of 174 patients considered to have undergone curative resection were studied. Circulating CRP concentrations were measured before and/or after operation. Results: The majority of patients were aged 65 years or more, had colonic tumours and Dukes' stage B lesions. During follow-up, 47 patients (27 per cent) developed recurrence and 59 (34 per cent) died. On univariate analysis, age (P < 0.01), Dukes' stage (P < 0.001), and CRP levels before (P < 0.01) and after (P < 0.01) operation were significantly associated with overall and cancer-specific survival. On multivariate analysis of patients in whom preoperative CRP concentration was measured, age (P < 0.01), Dukes' stage (P < 0.05) and CRP concentration (P < 0.01) were independently associated with both overall and cancer-specific survival. Conclusion: In patients who have undergone potentially curative resection for colorectal cancer, the presence of a systemic inflammatory response predicts a poor outcome.
引用
收藏
页码:215 / 219
页数:5
相关论文
共 13 条
  • [1] Stimulation of tumour growth by wound-derived growth factors
    Abramovitch, R
    Marikovsky, M
    Meir, G
    Neeman, M
    [J]. BRITISH JOURNAL OF CANCER, 1999, 79 (9-10) : 1392 - 1398
  • [2] Inflammation and cancer: back to Virchow?
    Balkwill, F
    Mantovani, A
    [J]. LANCET, 2001, 357 (9255) : 539 - 545
  • [3] Dorudi S, 1998, BRIT J SURG, V85, P98
  • [4] CLINICAL IMPLICATIONS OF METASTATIC PROCESS
    FROST, P
    LEVIN, B
    [J]. LANCET, 1992, 339 (8807) : 1458 - 1461
  • [5] BIOLOGY OF TUMOR-METASTASIS
    HART, IR
    SAINI, A
    [J]. LANCET, 1992, 339 (8807) : 1453 - 1457
  • [6] Outcome following surgery for colorectal cancer: analysis by hospital after adjustment for case-mix and deprivation
    McArdle, CS
    Hole, DJ
    [J]. BRITISH JOURNAL OF CANCER, 2002, 86 (03) : 331 - 335
  • [7] A PROSPECTIVE-STUDY OF TUMOR RECURRENCE AND THE ACUTE-PHASE RESPONSE AFTER APPARENTLY CURATIVE COLORECTAL-CANCER SURGERY
    MCMILLAN, DC
    WOTHERSPOON, HA
    FEARON, KCH
    STURGEON, C
    COOKE, TG
    MCARDLE, CS
    [J]. AMERICAN JOURNAL OF SURGERY, 1995, 170 (04) : 319 - 322
  • [8] Measurement of the systemic inflammatory response predicts cancer-specific and non-cancer survival in patients with cancer
    McMillan, DC
    Elahi, MM
    Sattar, N
    Angerson, WJ
    Johnstone, J
    McArdle, CS
    [J]. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2001, 41 (1-2): : 64 - 69
  • [9] Preoperative plasma plasminogen activator inhibitor type-1 and serum C-reactive protein levels in patients with colorectal cancer
    Nielsen, HJ
    Christensen, IJ
    Sorensen, S
    Moesgaard, F
    Brünner, N
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2000, 7 (08) : 617 - 623
  • [10] Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer
    Nozoe, T
    Matsumata, T
    Kitamura, M
    Sugimachi, K
    [J]. AMERICAN JOURNAL OF SURGERY, 1998, 176 (04) : 335 - 338